The Pharma Letter Podcast — Episode 7 — Better pharma supply chains

Simon Wentworth

16 November 2021

episode7-big

More on this story...

UK govt scraps COVID-19 vaccine supply deal with Valneva

13 September 2021

Galen — a privately owned pharmaceutical company — seeks partnerships and acquisitions to drive forward its growth ambitions and build on proud legacy

26 November 2021

Four tips for marketing in the pharma supply chain in a post-pandemic world

10 August 2021

The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?

10 February 2022

More ones to watch >

Today's issue

Lilly and Laekna team up on novel obesity drugs

Lilly and Laekna team up on novel obesity drugs

21 November 2024

Aizen hopes AI will help make mirror peptides a reality

21 November 2024

$30 million validation for Valora

21 November 2024

Astellas’ loss is Apellis’ gain as FDA setback shakes up prospects

21 November 2024

article

UK reappoints BIA chairman as life sciences investment envoy

21 November 2024

Sage scraps dalzanemdor after disappointing trial results

21 November 2024

Kura and Kyowa Kirin sign ziftomenib deal

21 November 2024

Company Spotlight

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.

More Features in Pharmaceutical

Sage scraps dalzanemdor after disappointing trial results

21 November 2024

Leading Tac secures $14 million for IRAK4 degraders

21 November 2024

Ascentage's lisaftoclax accepted for priority review in China

20 November 2024

Chris Boshoff takes on new role at Pfizer

20 November 2024

Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze